Filing Details
- Accession Number:
- 0000899243-24-000266
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-05 20:50:35
- Reporting Period:
- 2024-04-03
- Accepted Time:
- 2024-04-05 20:50:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1157601 | Madrigal Pharmaceuticals Inc. | MDGL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1423898 | Rebecca Taub | C/O Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428 | Pres., R&D, And Cmo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-03 | 27,845 | $9.45 | 486,844 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-03 | 135 | $242.00 | 486,709 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-03 | 2,634 | $243.68 | 484,075 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-03 | 4,070 | $244.68 | 480,005 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-03 | 18,917 | $245.34 | 461,088 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-03 | 2,089 | $246.32 | 458,999 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-04-04 | 18,537 | $9.45 | 477,536 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-04 | 4,200 | $240.88 | 473,336 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-04 | 5,619 | $241.85 | 467,717 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-04 | 3,085 | $242.71 | 464,632 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-04 | 435 | $244.01 | 464,197 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-04 | 2,734 | $245.06 | 461,463 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-04 | 1,653 | $246.01 | 459,810 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-04 | 711 | $247.23 | 459,099 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-04 | 100 | $248.23 | 458,999 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-04-05 | 27,506 | $9.45 | 486,505 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-05 | 1,643 | $240.11 | 484,862 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-05 | 700 | $241.14 | 484,162 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-05 | 8,817 | $242.61 | 475,345 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-05 | 8,989 | $243.33 | 466,356 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-05 | 2,079 | $244.45 | 464,277 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-05 | 5,278 | $245.53 | 458,999 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-03 | 27,845 | $0.00 | 27,845 | $9.45 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-04 | 18,537 | $0.00 | 18,537 | $9.45 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-05 | 27,506 | $0.00 | 27,506 | $9.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 125,283 | 2026-07-22 | No | 4 | M | Direct | |
| 106,746 | 2026-07-22 | No | 4 | M | Direct | |
| 79,240 | 2026-07-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 655,540 | Indirect | By SQN LLC |
Footnotes
- These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.11 to $244.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.11 to $245.10, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.11 to $246.10, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.12 to $246.70, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.33 to $241.29, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.37 to $242.36, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.38 to $243.35, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.40 to $244.39, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.49 to $245.47, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.52 to $246.50, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.78 to $247.68, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.57 to $240.52, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.67 to $241.64, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.00 to $242.99, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.00 to $243.95, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.03 to $245.02, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.03 to $245.88, inclusive.
- The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- The shares underlying this stock option are fully vested and exercisable.
Billionaire Hedge Funds
